Statement of Ownership (sc 13g)
February 13 2017 - 4:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
SCHEDULE 13G
Under the Securities Exchange Act of
1934
(Amendment No. ___)*
AC Immune SA
|
(Name of Issuer)
|
|
Common Shares
|
(Title of Class of Securities)
|
|
H00263 105
|
(CUSIP Number)
|
|
December 31, 2016
|
(Date of Event which Requires Filing of this Statement)
|
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
☐ Rule
13d-1(b)
☐ Rule
13d-1(c)
☒ Rule
13d-1(d)
________________________
* The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however,
see
the
Notes
).
Persons
who respond to the collection of information contained in this form are not required to respond unless the form displays a currently
valid OMB control number.
1.
|
NAMES OF REPORTING PERSONS
Andrea Pfeifer
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐
|
|
|
(b) ☐
|
3.
|
SEC USE ONLY
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
German
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5.
|
SOLE VOTING POWER
3,076,500 (1)
|
6.
|
SHARED VOTING POWER
0
|
7.
|
SOLE DISPOSITIVE POWER
3,076,500 (1)
|
8.
|
SHARED DISPOSITIVE POWER
0
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,076,500 (1)
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES
☐
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.46% (2)
|
12.
|
TYPE OF REPORTING PERSON
IN
|
|
(1)
|
Consists of 2,908,500 common shares held by the reporting person and options to purchase 168,000 common shares exercisable
within 60 days of December 31, 2016.
|
|
(2)
|
Based on 56,296,042 common shares outstanding as of September 30, 2016.
|
Item 1(a). Name of Issuer:
AC Immune SA
Item 1(b). Address of Issuer’s
Principal Executive Offices:
EPFL Innovation Park, bâtiment B,
1015 Lausanne, Switzerland
Item 2(a). Name of Person
Filing:
Andrea Pfeifer
Item 2(b). Address of Principal
Business Office or, if None, Residence:
EPFL Innovation Park, bâtiment B,
1015 Lausanne, Switzerland
Item 2(c). Citizenship:
German
Item 2(d). Title of Class
of Securities:
Common shares, nominal value CHF 0.02 per
share
Item 2(e). CUSIP Number:
H00263 105
Item 3. If this Statement
is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
Item 4. Ownership.
Provide the following information regarding
the aggregate number and percentage of the class of securities of issuer identified in Item 1.
|
(a)
|
Amount beneficially owned: 3,076,500 common shares, consisting of 2,908,500 common shares held by the reporting person and
options to purchase 168,000 common shares exercisable within 60 days of December 31, 2016.
|
|
(b)
|
Percent of class: 5.46%, based on 56,296,042 common shares outstanding as of September 30, 2016
|
|
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 3,076,500
|
|
(ii)
|
Shared power to vote or to direct the vote: 0
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: 3,076,500
|
|
(iv)
|
Shared power to dispose or to direct the disposition of: 0
|
Item 5. Ownership of Five
Percent or Less of a Class.
N/A
Item 6. Ownership of More
than Five Percent on Behalf of Another Person.
N/A
Item 7. Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
N/A
Item 8. Identification
and Classification of Members of the Group.
N/A
Item 9. Notice of Dissolution
of Group.
N/A
Item 10. Certifications.
N/A
SIGNATURE
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
February 13, 2017
|
|
(Date)
|
|
/s/ Andrea Pfeifer
|
|
(Signature)
|
|
Andrea Pfeifer
|
|
(Name)
|
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Mar 2024 to Apr 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Apr 2023 to Apr 2024